Huapont-Nutrichem Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Huapont-Nutrichem Co Ltd with three other
companies in this sector in China:
Chongqing Taiji Industry (Group)
sales of 8.73 billion Chinese Renmimbi [US$1.27 billion]
of which 68%
Livzon Pharmaceutical Group Incorporated
(8.53 billion Chinese Renmimbi [US$1.24 billion]
of which 43%
was Western Medicine), and
Shanghai Shyndec Pharmaceutical Co Ltd
(8.52 billion Chinese Renmimbi [US$1.24 billion]
of which 60%
was Drug Products).
During the year ended December of 2017, sales at
Huapont-Nutrichem Co Ltd were 9.11 billion Chinese Renmimbi (US$1.33 billion).
increase of 28.4%
versus 2016, when the company's sales were 7.09 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Huapont-Nutrichem Co Ltd
(and since 2012, sales have increased a total of 135%).
Sales of Headquarters saw an increase
that was more than double the company's growth rate: sales were up
449.5% in 2017, from
4.04 million Chinese Renmimbi to 22.20 million Chinese Renmimbi.
Huapont-Nutrichem Co Ltd also saw significant increases in sales in
Tourism (up 84.1% to 100.57 million Chinese Renmimbi)
Other (up 68.4% to 129.60 million Chinese Renmimbi)